Veterinary Medicines

Cryptisel 0.5 mg/ml oral solution for calves

Authorised
  • Halofuginone lactate
Download as PDF

Product identification

Medicine name:
Cryptisel 0.5 mg/ml oral solution for calves
Cryptisel 0,5 mg/ml Lösung zum Eingeben für Kälber
Active substance:
  • Halofuginone lactate
Target species:
  • Cattle (newborn calf)
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Halofuginone lactate
    0.61
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cattle (newborn calf)
      • Meat and offal
        13
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP51BX01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • box containing 1 bottle of 1000 ml (containing 980 ml of soluci?n)
  • box containing 1 bottle of 500 ml (containing 490 ml of soluci?n)
  • box containing 1 bottle of 300 ml (containing 290 ml of soluci?n)
  • box containing 1 bottle of 1000 ml (containing 980 ml of soluci?n) with a 4 ml metering pump
  • box containing 1 bottle of 500 ml (containing 490 ml of soluci?n) with a 4 ml metering pump
  • box containing 1 bottle of 300 ml (containing 290 ml of soluci?n) with a 4 ml metering pump

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Industrial Veterinaria S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Industrial Veterinaria S.A.
  • aniMedica GmbH
  • aniMedica Herstellungs GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402732.00.00
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0374/001
Concerned member states:
  • Austria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 24/03/2023
Download
German (PDF)
Published on: 10/01/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 10/01/2025
Download

Combined File of all Documents

English (PDF)
Published on: 24/07/2025
Download

eu-PUAR-cryptisel-0.5-mg-ml-oral-solution-for-calves-en.pdf

English (PDF)
Published on: 12/04/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."